Coinspeaker GILD Stock Up 0.2% in Pre-market, European Union Inks Deal with Gilead Sciences for Remdesivir SupplyAs it was proven that Remdesivir could reduce the risk of death from COVID-19, the EU has entered in agreement with Gilead for 30,000 of its antiretroviral drug doses. GILD stock is up in the pre-market.GILD Stock Up 0.2% in Pre-market, European Union Inks Deal with Gilead Sciences for Remdesivir Supply
